• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Chermaine Lee

Articles by Chermaine Lee

RDT use rising in India in fight against malaria

Jan. 30, 2019
By Chermaine Lee

Malaysia med tech sees slower investment in 2018

Jan. 28, 2019
By Chermaine Lee

Japan OKs Qiagen's EGFR diagnostic kit for lung cancer

Jan. 23, 2019
By Chermaine Lee

Japan's Olympus eyes transformation

Jan. 16, 2019
By Chermaine Lee

Personal Genome, Kingmed to commercialize PGDx elio assays in China, Hong Kong

Jan. 16, 2019
By Chermaine Lee
HONG KONG – American firm Personal Genome Diagnostics Inc. (PGDx) has partnered with China laboratory services provider Guangzhou Kingmed Diagnostics Group Co. Ltd. (Kingmed) to commercialize the cancer detection product PGDx elio assays on the Chinese mainland and in Hong Kong.
Read More

Solasia kicks off Asia enrollment of phase III testing of Pledox in CIPN

Jan. 16, 2019
By Chermaine Lee
HONG KONG – After inking a deal last year worth $83 million with Swedish biotech firm Pledpharma AB to acquire the exclusive rights to develop and commercialize Pledox, Japan's Solasia Pharma KK has started the molecule's phase III development in Asia. It's part of a global phase III trial testing the compound, which is used to suppress the development of peripheral neuropathy in colorectal cancer patients.
Read More

Personal Genome, Kingmed to commercialize PGDx elio assays in China, Hong Kong

Jan. 14, 2019
By Chermaine Lee

Solasia kicks off Asia enrollment of phase III testing of Pledox in CIPN

Jan. 14, 2019
By Chermaine Lee
HONG KONG – After inking a deal last year worth $83 million with Swedish biotech firm Pledpharma AB to acquire the exclusive rights to develop and commercialize Pledox, Japan's Solasia Pharma KK has started the molecule's phase III development in Asia. It's part of a global phase III trial testing the compound, which is used to suppress the development of peripheral neuropathy in colorectal cancer patients.
Read More

Personal Genome, Kingmed to commercialize PGDx elio assays in China, Hong Kong

Jan. 14, 2019
By Chermaine Lee
HONG KONG – American firm Personal Genome Diagnostics Inc. (PGDx) has partnered with China laboratory services provider Guangzhou Kingmed Diagnostics Group Co. Ltd. (Kingmed) to commercialize the cancer detection product PGDx elio assays on the Chinese mainland and in Hong Kong.
Read More

Merger agreement combines China's HJB, Mabspace to form biotherapeutic powerhouse

Jan. 9, 2019
By Chermaine Lee
HONG KONG – China bioprocessing technology firm Hangzhou Just Biotherapeutics Ltd. (HJB) and clinical-stage biotech Mabspace Biosciences Co. Ltd. have entered a merger agreement to establish a biotherapeutics maker, Transcenta Holding Ltd., with the aim of shortening the time from target to biologics license applications, and setting up a next-generation GMP facility that supports the development and commercialization of molecules both in-house and from its partners.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 11, 2025.
  • Antibodies

    Abbvie gains rights to IGI’s trispecific ISB-2001 in $1.9B+ deal

    BioWorld
    Nearly six years after Ichnos Sciences Inc. launched operations, a subsidiary of the now-named Ichnos Glenmark Innovation (IGI) Inc. has signed with Abbvie Inc. a...
  • PTAB hands Exact a loss in Geneoscopy patent dispute

    BioWorld MedTech
    The med tech patent wars opened a new front in the region of screening tests for colorectal cancer, pitting Exact Sciences Corp., of Madison, Wisc., against St....
  • Document illustration

    US FDA finally taking the wraps off CRLs

    BioWorld
    It’s been more than seven years in coming, but the U.S. FDA is at last making public at least some of the complete response letters (CRLs) it’s sent to drug and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe